Alvaro Alvarez Soto(he/him/his)
@alvarezsoto.bsky.social
-Hematology/oncology fellow at UCONN Health.
-Passionate about health equity, global oncology, racial and ethnic disparities, Biomarkers in cancer.
-Passionate about health equity, global oncology, racial and ethnic disparities, Biomarkers in cancer.
Reviewing next generation sequencing (NGS) from patients in the clinic is always interesting.
So many TP53 mutations and all of them seem different from patient to patient.
From CLL to uterine cancer, TP53 is used to risk stratify many cancer types. TP53 is anywhere you look!
So many TP53 mutations and all of them seem different from patient to patient.
From CLL to uterine cancer, TP53 is used to risk stratify many cancer types. TP53 is anywhere you look!
December 28, 2024 at 6:04 PM
Reviewing next generation sequencing (NGS) from patients in the clinic is always interesting.
So many TP53 mutations and all of them seem different from patient to patient.
From CLL to uterine cancer, TP53 is used to risk stratify many cancer types. TP53 is anywhere you look!
So many TP53 mutations and all of them seem different from patient to patient.
From CLL to uterine cancer, TP53 is used to risk stratify many cancer types. TP53 is anywhere you look!
Using the SEER database we are finding significant difference in pathological complete response between Black and White women with early stage Breast Cancer. Achieving pCR equalizes outcomes when all groups are combined.
December 12, 2024 at 7:12 PM
Using the SEER database we are finding significant difference in pathological complete response between Black and White women with early stage Breast Cancer. Achieving pCR equalizes outcomes when all groups are combined.
Reposted by Alvaro Alvarez Soto(he/him/his)
Presented at #SABCS24:
This clinical trial found that among women with low-risk DCIS, active monitoring did not lead to higher rates of invasive breast cancer vs those who received guideline-concordant care.
ja.ma/3VArtv0
This clinical trial found that among women with low-risk DCIS, active monitoring did not lead to higher rates of invasive breast cancer vs those who received guideline-concordant care.
ja.ma/3VArtv0
December 12, 2024 at 4:04 PM
Presented at #SABCS24:
This clinical trial found that among women with low-risk DCIS, active monitoring did not lead to higher rates of invasive breast cancer vs those who received guideline-concordant care.
ja.ma/3VArtv0
This clinical trial found that among women with low-risk DCIS, active monitoring did not lead to higher rates of invasive breast cancer vs those who received guideline-concordant care.
ja.ma/3VArtv0
December always takes me to San Antonio channels #SABCS #BreastCancer
December 9, 2024 at 11:20 PM
December always takes me to San Antonio channels #SABCS #BreastCancer
Some results from our poster using the SEER database looking into outcomes disparities by race and socioeconomic status. Low socioeconomic status (SEE) means lower survival. When we stratify by race, Low SES means higher hazard risk of death in White and Hispanics but not in Black patients. #ASH
December 8, 2024 at 1:41 AM
Some results from our poster using the SEER database looking into outcomes disparities by race and socioeconomic status. Low socioeconomic status (SEE) means lower survival. When we stratify by race, Low SES means higher hazard risk of death in White and Hispanics but not in Black patients. #ASH
Tomorrow morning we will have our Global Oncology and disparities of care program!
Genetic testing/counseling for patients at risk is common in the US, but great opportunity to learn about their implementation in LMICs.
Link to register:
docs.google.com/forms/d/e/1F...
Genetic testing/counseling for patients at risk is common in the US, but great opportunity to learn about their implementation in LMICs.
Link to register:
docs.google.com/forms/d/e/1F...
November 20, 2024 at 11:22 PM
Tomorrow morning we will have our Global Oncology and disparities of care program!
Genetic testing/counseling for patients at risk is common in the US, but great opportunity to learn about their implementation in LMICs.
Link to register:
docs.google.com/forms/d/e/1F...
Genetic testing/counseling for patients at risk is common in the US, but great opportunity to learn about their implementation in LMICs.
Link to register:
docs.google.com/forms/d/e/1F...